Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Filings indexed 2,009 across all filing types
Latest filing 2019-04-23 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
2018年年度报告
Annual Report Classification · 100% confidence The document is titled "成都市贝瑞和康基因技术股份有限公司 2018 年年度报告全文" which translates to "Berry Genomics Co., Ltd. 2018 Annual Report Full Text." It contains detailed sections typical of an annual report, including company overview, financial data for the year 2018, business summary, management discussion, governance, and financial statements. The document length is about 15,000 characters, indicating a full report rather than a brief announcement. There are no indications that this is merely a notice of report publication or a certification. The content includes comprehensive financial data, business analysis, and company information for the full fiscal year 2018. Therefore, this document fits the definition of an Annual Report (10-K). FY 2018
2019-04-23 Chinese
中信建投证券股份有限公司关于公司发行股份购买资产及重大资产出售暨关联交易之2018年度独立财务顾问持续督导报告书
Audit Report / Information Classification · 95% confidence The document is titled as an "Independent Financial Advisor Continuous Supervision Report" related to a major asset purchase and sale transaction by Chengdu Berry Genomics Co., Ltd. It includes detailed information about the transaction, asset transfer, share issuance, and compliance with regulatory approvals. The document is a comprehensive report by an independent financial advisor on the ongoing supervision of a significant asset restructuring and share issuance event, including verification of asset delivery, share registration, and fulfillment of commitments by transaction parties. It is not a simple announcement or a brief summary but a detailed advisory report related to a major asset restructuring transaction. This fits the category of an Audit Report / Information (AR), as it involves independent financial advisory and verification related to a major asset transaction and compliance, rather than a full annual report or other categories like capital update or management changes. FY 2018
2019-04-23 Chinese
发行股份购买资产之标的资产业绩承诺完成情况的专项审核报告
Capital/Financing Update Classification · 95% confidence The document is a detailed explanation regarding the completion status of performance commitments related to an asset purchase transaction involving share issuance. It discusses the background of the transaction, regulatory approvals, and the specific performance compensation agreements tied to the acquisition. The content focuses on the asset purchase, performance guarantees, and related financial obligations rather than presenting a full financial report or earnings data. The document length is relatively short (3009 characters) and it does not contain comprehensive financial statements or quarterly/yearly financial results. It is not a report publication announcement since it contains substantive explanation rather than just a notice. The document is best classified as a Capital/Financing Update (CAP) because it relates to the issuance of shares to purchase assets and the associated performance commitments and compensation mechanisms.
2019-04-23 Chinese
关于聘请2019年度财务和内部控制审计机构的公告
Audit Report / Information Classification · 90% confidence The document is an announcement regarding the appointment of an audit firm for the company's 2019 financial and internal control audit. It details the audit firm's qualifications, the board's approval process, and the independent directors' opinions. The document does not contain any actual audit report, financial statements, or audit results. It is a formal announcement about hiring the audit firm rather than the audit report itself. The document length is short (1821 characters), and it serves as a notice of the audit engagement. Therefore, it fits best under Audit Report / Information (AR) as it relates to audit information but is not the full annual report or audit report itself. However, since it is an announcement of the appointment of the audit firm rather than the audit report or results, and given the definitions, the best fit is Audit Report / Information (AR) because it concerns audit-related information and is not a mere regulatory filing or report publication announcement. FY 2019
2019-04-23 Chinese
关于2018年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the 2018 annual profit distribution plan of the company, including details about no cash dividends, no bonus shares, and no capital reserve conversion to shares. It includes opinions from the board of directors, independent directors, and the supervisory board. The document does not contain full financial statements or comprehensive financial performance data but rather focuses on the dividend distribution plan and related approvals. This fits the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and related details to shareholders. The document length is short (1394 characters), and it is not a full annual report or earnings release but a specific announcement about profit distribution.
2019-04-23 Chinese
2018年度内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2018 年度内部控制评价报告' which translates to '2018 Annual Internal Control Evaluation Report'. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2018. The content includes detailed descriptions of internal control scope, evaluation criteria, risk areas, and conclusions about the absence of major deficiencies. It is a standalone report focused on internal control evaluation, not a full annual report or financial statement. There is no indication that this is an announcement or a certification letter. The document fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and internal control evaluation results. Therefore, the appropriate classification is AR with high confidence. FY 2018
2019-04-23 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.